MEASUREMENT OF LIVER MICROSOMAL CYTOCHROME-P450 (CYP2D6) ACTIVITY USING [O-METHYL-C-14] DEXTROMETHORPHAN

被引:63
作者
RODRIGUES, AD [1 ]
KUKULKA, MJ [1 ]
SURBER, BW [1 ]
THOMAS, SB [1 ]
UCHIC, JT [1 ]
ROTERT, GA [1 ]
MICHEL, G [1 ]
THOMEKROMER, B [1 ]
MACHINIST, JM [1 ]
机构
[1] ABBOTT LABS, D-65205 WIESBADEN, GERMANY
关键词
D O I
10.1006/abio.1994.1271
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The activity of human liver microsomal cytochrome P4502D6 (CYP2D6) is readily estimated by following the O-demethylation of [O-nethyl-C-14]dextromethorphan. The basis of the assay is the quantitative measurement of [C-14]formaldehyde (0.05-4.0 mu m) after addition of NaOH to the microsomal incubates and extraction with methylene chloride. The assay is relatively simple, sensitive (limit of detection is similar to 5.0 pmol HCHO/h/mg microsomal protein) and does not require the use of HPLC or an internal standard. Formation of radiolabeled formaldehyde in human liver microsomes is linear for 20 min, up to a final protein concentration of 1.0 mg/ml. Furthermore, the O-demethylase activity in a panel of microsomes prepared from a series of human livers was significantly correlated with the immunochemically determined levels of CYP2D6 protein (r = 0.925, p < 0.001), and was inhibited (>89%) by quinidine and lobeline. In addition, [O-methyl-C-14]dextromethorphan O-demethylation was exclusively catalyzed by cDNA-expressed CYP2D6 in microsomes prepared from human B-lymphoblast cells. The method is suitable for rapid screening of compounds as potential CYP2D6 cosubstrates and/or inhibitors. (C) 1994 Academic Press, Inc.
引用
收藏
页码:309 / 320
页数:12
相关论文
共 54 条
[1]   FLUORIMETRIC DETERMINATION OF FORMALDEHYDE [J].
BELMAN, S .
ANALYTICA CHIMICA ACTA, 1963, 29 (02) :120-&
[2]  
Black T. H., 1983, ALDRICHIM ACTA, V16, P3
[3]   EXTENSIVE METABOLIZERS OF DEBRISOQUINE BECOME POOR METABOLIZERS DURING QUINIDINE TREATMENT [J].
BROSEN, K ;
GRAM, LF ;
HAGHFELT, T ;
BERTILSSON, L .
PHARMACOLOGY & TOXICOLOGY, 1987, 60 (04) :312-314
[4]  
CRESPI CL, 1991, METHOD ENZYMOL, V206, P123
[5]   A METABOLICALLY COMPETENT HUMAN CELL-LINE EXPRESSING 5 CDNAS ENCODING PROCARCINOGEN-ACTIVATING ENZYMES - APPLICATION TO MUTAGENICITY TESTING [J].
CRESPI, CL ;
GONZALEZ, FJ ;
STEIMEL, DT ;
TURNER, TR ;
GELBOIN, HV ;
PENMAN, BW ;
LANGENBACH, R .
CHEMICAL RESEARCH IN TOXICOLOGY, 1991, 4 (05) :566-572
[6]  
CREWE HK, 1991, BR J CLIN PHARM, V32, P658
[7]   DEXTROMETHORPHAN O-DEMETHYLATION IN LIVER-MICROSOMES AS A PROTOTYPE REACTION TO MONITOR CYTOCHROME-P-450 DB1 ACTIVITY [J].
DAYER, P ;
LEEMANN, T ;
STRIBERNI, R .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (01) :34-40
[8]  
DAYER P, 1987, SCHWEIZ MED WSCHR, V117, P1971
[9]  
DIXON R, 1978, RES COMMUN CHEM PATH, V22, P243
[10]   DETERMINATION OF DEXTROMETHORPHAN AND METABOLITES IN HUMAN-PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION [J].
EAST, T ;
DYE, D .
JOURNAL OF CHROMATOGRAPHY, 1985, 338 (01) :99-112